Biotricity (BTCY) Expected to Announce Quarterly Earnings on Wednesday

Biotricity (NASDAQ:BTCY) will likely be releasing its results after the market closes on Wednesday, February 11th. Analysts expect Biotricity to post earnings of ($0.08) per share and revenue of $4.10 million for the quarter.

Biotricity Stock Up 10.7%

Shares of NASDAQ BTCY traded up $0.03 during midday trading on Monday, hitting $0.28. The stock had a trading volume of 22,182 shares, compared to its average volume of 59,015. The business’s 50 day moving average is $0.33 and its 200-day moving average is $0.48. Biotricity has a 52 week low of $0.23 and a 52 week high of $0.83. The company has a market cap of $7.74 million, a P/E ratio of -0.26 and a beta of 1.52.

Biotricity Company Profile

Biotricity, Inc (NASDAQ:BTCY) is a digital health company specializing in remote patient monitoring solutions across cardiovascular and chronic disease management. The firm develops and commercializes a patented wearable biosensor platform designed to capture continuous physiological data, including electrocardiogram (ECG) readings and heart rate variability. This integrated system combines lightweight, adhesive biosensors with cloud-based analytics and clinician-facing software to support early detection of cardiac arrhythmias and facilitate telehealth care delivery.

The company’s flagship offering, the Bioflux™ platform, comprises a small, single-use wearable device that transmits real-time data to a secure portal, where advanced algorithms analyze cardiac patterns and generate clinician alerts.